Academic Journal
Mouvements anormaux iatrogènes : aspects nosologiques et thérapeutiques. ; Drug-induced movement disorders : nosology and treatment.
| Title: | Mouvements anormaux iatrogènes : aspects nosologiques et thérapeutiques. ; Drug-induced movement disorders : nosology and treatment. |
|---|---|
| Authors: | MARTEN, Laurie, Depierreux, Frédérique |
| Contributors: | GIGA CRC In vivo Imaging - Rare Movement Disorders Research Group - ULiège |
| Source: | Revue Médicale de Liège, 79 (2), 88 - 93 (2024-02-20) |
| Publisher Information: | Université de Liège. Revue Médicale de Liège |
| Publication Year: | 2024 |
| Collection: | University of Liège: ORBi (Open Repository and Bibliography) |
| Subject Terms: | Acute movement disorders, Dopamine-receptor blocking agents, Neuroleptics, Tardive syndromes, Antipsychotic Agents, Humans, Syndrome, Movement Disorders/diagnosis, Movement Disorders/etiology, Movement Disorders/therapy, Antipsychotic Agents/adverse effects, Human health sciences, Neurology, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Neurologie, Pharmacie, pharmacologie & toxicologie |
| Description: | editorial reviewed ; Movements disorders are frequently encountered in general practice and emergency departments and are in many cases of iatrogenic origin. Dopamine D2 receptor blocking agents (DRBA), mainly neuroleptics, are most often incriminated. These drug-induced movement disorders (DIMD) can be classified according to the kinetics of the manifestations (acute DIMD and tardive syndromes), the phenomenology of the abnormal movements observed or depending on the pharmacological agent involved. The diagnosis is based on the time course of the events, clinical examination and meticulous anamnesis of the patient's previous and current treatments. Management is always based on the interruption of the suspected causal treatment when possible. Some cases have a severe prognosis and require immediate treatment. ; Les mouvements anormaux sont fréquemment rencontrés en médecine générale et aux urgences et sont, dans de nombreux cas, d’origine iatrogène. Les molécules les plus souvent incriminées sont les agents bloqueurs des récepteurs dopaminergiques D2 (DRBA) et principalement les neuroleptiques. Ces mouvements anormaux iatrogènes (MAI) peuvent être classés selon la cinétique des manifestations (MAI aigus et syndromes tardifs), la sémiologie des mouvements observés, ou encore, selon l’agent pharmacologique en cause. Le diagnostic repose sur le décours temporel des manifestations, l’examen clinique et une anamnèse fouillée des traitements antérieurs et actuels du patient. La prise en charge repose toujours sur l’arrêt du traitement causal quand cela est possible. Il existe des situations urgentes grevées d’un pronostic sévère et redevables d’un traitement rapide. |
| Document Type: | article in journal/newspaper |
| Language: | French |
| ISSN: | 0370-629X 2566-1566 |
| Relation: | urn:issn:0370-629X; urn:issn:2566-1566; https://orbi.uliege.be/handle/2268/313424; info:hdl:2268/313424; https://orbi.uliege.be/bitstream/2268/313424/1/Mvts_anormaux_iatrog%c3%a8nes_Depierreux_Marten_2024.pdf; info:pmid:38356424 |
| Availability: | https://orbi.uliege.be/handle/2268/313424 https://orbi.uliege.be/bitstream/2268/313424/1/Mvts_anormaux_iatrog%c3%a8nes_Depierreux_Marten_2024.pdf |
| Rights: | open access ; http://purl.org/coar/access_right/c_abf2 ; info:eu-repo/semantics/openAccess |
| Accession Number: | edsbas.3B9E2C30 |
| Database: | BASE |
| ISSN: | 0370629X 25661566 |
|---|